Lehman Amanda

Kandarakis Stylianos A, Petrou Petros, Katsimpris Andreas, Papakonstantinou Evangelia, Timpilis Marios, Chronopoulou Konstantina et al.

Comparing Ahmed vs. Baerveldt implants in vitrectomized eyes, Baerveldt achieved lower IOP and fewer medications at 2 years, despite similar success rates and more complications, offering better IOP control.

Adetunji Modupe O, Meer Elana, Whitehead Gideon, Hua Peiying, Badami Avni, Addis Victoria et al.

This study found Black patients undergoing prophylactic LPI for angle closure have higher risks of post-procedure IOP elevation and iritis, suggesting increased vigilance and medication are needed.

Meer Elana, Liu Tianyu, Hua Peiying, Ying Gui-Shuang, Miller Eydie, Lehman Amanda

This study found no significant long-term differences in IOP or medication reduction among Hydrus, iStent, and Kahook MIGS procedures in a predominantly African American population.

O'Brien Joan M, Salowe Rebecca J, Fertig Raymond, Salinas Julia, Pistilli Maxwell, Sankar Prithvi S et al.

Studying African Americans, positive family history significantly increases glaucoma risk, leading to earlier onset and potentially more severe disease, highlighting strong genetic influences.